Ozanimod
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
5-(3-{(1S)-1-[(2-Hydroxyethyl)amino]-2,3-dihydro-1H-inden-4-yl}-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1306760-87-1 |
PubChem | CID: 52938427 |
ChemSpider | 34979946 |
Synonyms | RPC1063 |
Chemical data | |
Formula | C23H24N4O3 |
Molecular mass | 404.46 g/mol |
|
|
|
Ozanimod is an experimental drug for the treatment of multiple sclerosis and ulcerative colitis.[1] It is an immunotherapy that modulates the sphingosine-1-phosphate 1 receptor.[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Oxadiazoles
- Nitriles
- Indanes
- Pharmacology stubs